Therefore, the knockdown of FOXO3a in glioblastoma multiforme stem cells with intact p53 activity can significantly enhance the response to treatment with radiation therapy combined with PI3K/mTOR inhibition [136]. The gene discussed is TP53; the disease is glioblastoma.